45
Participants
Start Date
August 8, 2024
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
Omicron BA.5 SARS-CoV-2 challenge virus
The SARS-CoV-2 challenge virus strain was originally obtained from a nose/throat swab taken from a patient who developed respiratory symptoms consistent with Covid-19. All manufacturing steps are carried out in accordance with GMP by BioMARC, operating out of Colorado State University.
Centre for Clinical Vaccinology and Tropical Medicine, Oxford
University of Oxford
OTHER